BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shariq AS, Rosenblat JD, Alageel A, Mansur RB, Rong C, Ho RC, Ragguett R, Pan Z, Brietzke E, Mcintyre RS. Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019;92:1-7. [DOI: 10.1016/j.pnpbp.2018.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Shigetsura Y, Imai S, Endo H, Shimizu Y, Ueda K, Murai T, Itohara K, Nakagawa S, Yonezawa A, Ikemi Y, Fukatsu S, Kitada N, Terada T, Nakagawa T, Matsubara K. Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder. Clin Neuropharm 2022;Publish Ahead of Print. [DOI: 10.1097/wnf.0000000000000499] [Reference Citation Analysis]
2 Dhuna NA, Malkani RG. Antidepressants and Their Impact on Sleep. Curr Sleep Medicine Rep 2020;6:216-25. [DOI: 10.1007/s40675-020-00189-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lefter R, Cojocariu RO, Ciobica A, Balmus I, Mavroudis I, Kis A. Interactions between Sleep and Emotions in Humans and Animal Models. Medicina 2022;58:274. [DOI: 10.3390/medicina58020274] [Reference Citation Analysis]
4 Al-Kuraishy HM, Abdulhadi MH, Hussien NR, Al-Niemi MS, Rasheed HA, Al-Gareeb AI. Involvement of orexinergic system in psychiatric and neurodegenerative disorders: A scoping review. Brain Circ 2020;6:70-80. [PMID: 33033776 DOI: 10.4103/bc.bc_42_19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
5 Akça ÖF, Uzun N, Kılınç İ. Orexin A in adolescents with anxiety disorders. International Journal of Psychiatry in Clinical Practice 2020;24:127-34. [DOI: 10.1080/13651501.2019.1711425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 McIntyre RS, Berk M, Brietzke E, Goldstein BI, López-Jaramillo C, Kessing LV, Malhi GS, Nierenberg AA, Rosenblat JD, Majeed A, Vieta E, Vinberg M, Young AH, Mansur RB. Bipolar disorders. Lancet 2020;396:1841-56. [PMID: 33278937 DOI: 10.1016/S0140-6736(20)31544-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 19] [Article Influence: 45.0] [Reference Citation Analysis]
7 Rajkumar RP. Harnessing the Neurobiology of Resilience to Protect the Mental Well-Being of Healthcare Workers During the COVID-19 Pandemic. Front Psychol 2021;12:621853. [PMID: 33815205 DOI: 10.3389/fpsyg.2021.621853] [Reference Citation Analysis]
8 Anderson G, Rodriguez M, Reiter RJ. Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells. Int J Mol Sci 2019;20:E5500. [PMID: 31694154 DOI: 10.3390/ijms20215500] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
9 Crouse JJ, Carpenter JS, Song YJC, Hockey SJ, Naismith SL, Grunstein RR, Scott EM, Merikangas KR, Scott J, Hickie IB. Circadian rhythm sleep-wake disturbances and depression in young people: implications for prevention and early intervention. Lancet Psychiatry 2021;8:813-23. [PMID: 34419186 DOI: 10.1016/S2215-0366(21)00034-1] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Gabery S, Ahmed RM, Caga J, Kiernan MC, Halliday GM, Petersén Å. Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 2021. [PMID: 33755993 DOI: 10.1111/nan.12709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Pitsillou E, Bresnehan SM, Kagarakis EA, Wijoyo SJ, Liang J, Hung A, Karagiannis TC. The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression. Mol Biol Rep 2020;47:753-70. [PMID: 31612411 DOI: 10.1007/s11033-019-05129-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
12 Akça ÖF, Sağlam E, Kılınç I, Bilgiç A. Orexin a levels of adolescents with major depressive disorder. Int J Psychiatry Clin Pract 2021;:1-4. [PMID: 34032542 DOI: 10.1080/13651501.2021.1927106] [Reference Citation Analysis]